
Opioid use incidence and prevalence rates decreased with implementation of an opioid safety initiative, whereas nonsteroidal anti-inflammatory drug rates remained constant. Rates of adverse events were higher among opioid users.
Opioid use incidence and prevalence rates decreased with implementation of an opioid safety initiative, whereas nonsteroidal anti-inflammatory drug rates remained constant. Rates of adverse events were higher among opioid users.
After the FDA warning and removal of rosiglitazone from the VA National Formulary, glucose control may have declined among those discontinuing rosiglitazone without receiving replacement medication.
A higher proportion of veterans who use VA pharmacy services are black, have no alternative insurance, have lower incomes, are disabled, and report poorer health.
Published: May 1st 2007 | Updated:
Published: June 7th 2008 | Updated:
Published: March 15th 2018 | Updated:
Published: October 8th 2009 | Updated:
Published: September 19th 2013 | Updated:
259 Prospect Plains Rd, Bldg H
Monroe, NJ 08831
© 2025 MJH Life Sciences®
All rights reserved.